ETON stock forecast
Our latest prediction for Eton Pharmaceuticals Inc's stock price was made on the Oct. 16, 2020 when the stock price was at 7.73$.
In the short term (2weeks), ETON's stock price should underperform the market by -0.41%. During that period the price should oscillate between -10.21% and +12.85%.
In the medium term (3months), ETON's stock price should underperform the market by -7.02%. During that period the price should oscillate between -43.57% and +27.11%.Get email alerts
Create a solid portfolio with ETON
About Eton Pharmaceuticals Inc
Eton Pharmaceuticals, Inc. is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The company currently owns or receives royalties from three FDA-approved products, including ALKINDI® SPRINKLE, Biorphen®, and Alaway® Preservative Free, and has six additional products that have been submitted to the FDA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -1.33$ per share.
The book value per share is 1.09$
Three months stock forecastOct. 16, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|